Daina Graybosch

Work

Analyst Daina Graybosch works at LEERINK and is focused on the Healthcare sector with 208 price targets and ratings documented since 2019 spanning on 18 stocks. Analyst's average stock valuation to be materialised ratio is 31.5% with an average time for price targets to be met of 117.12 days.

Most recent stock forecast was given on MRK, Merck & Co., Inc at 03-Feb-2023.

Daina Graybosch best performing recommendations are on SBTX (SILVERBACK THERAPEUTICS INC).
The best stock recommendation documented was for SBTX (SILVERBACK THERAPEUTICS INC) at 12/29/2020. The price target of $40 was fulfilled within 1 day with a profit of $3 (8.11%) receiving and performance score of 81.08.

Average potential price target upside

ACLX BNTX FATE MRK SBTX AFMD CGEN IPHA IPSC ITOS MOLN NKTR BOLT FSTX HOWL LVTX TSVT RCUS

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

37

$3.63 (10.88%)

24

1 months 24 days ago

1/2 (50%)

$6.41 (30.62%)

100

Buy

38

$4.63 (13.87%)

25

1 months 25 days ago

1/2 (50%)

$8.89 (41.47%)

282

Buy

35

$1.63 (4.88%)

31

1 months 25 days ago

1/2 (50%)

$8.54 (37.34%)

47

Buy

34

$0.63 (1.89%)

32

1 months 25 days ago

1/2 (50%)

$8.59 (38.43%)

147

Show more analysts
ACLX BNTX FATE MRK SBTX AFMD CGEN IPHA IPSC ITOS MOLN NKTR BOLT FSTX HOWL LVTX TSVT RCUS